Draximage Report issue

Contributed to NME For profit Phase 2
Founded: Kirkland QC Canada (1955)
Status: Acquired by Jubilant DraxImage Inc. (2008) → now Jubilant Innovation Ltd. (1978)

Organization Overview

First Clinical Trial
None
First Marketed Drug
1982
tc-99m gluceptate (glucoscan)
First NDA Approval
1986
technetium tc-99m lidofenin kit (technescan hida)
Last Known Activity
1987

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Deprenyl | DRAXIMAGE

Active Ingredients

Marketed Drugs (3)

tc-99m albumin (1987)

tc-99m gluceptate (glucoscan) (1982)

technetium tc-99m lidofenin kit (technescan hida) (1986 NDA)

Drugs in Phase 2 Trials (2)

Key: Draximage (0) Acquired (2)

2-hydroxyoleic acid (3 trials)

temozolomide (temodar) (2 trials)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 3
  • # of Trial APIs: 2